Nexalin Technology, Inc. (NXL): Cash & Equivalents

Annual figures by period end, from SEC filings.

$654.8K
As of 2025-12-31
$1.00M
As of 2026-06-30
+59.0%
3-year compound annual growth
$661.8K2021-12-31: $661.8K2022-12-31: $162.7K2023-12-31: $580.2K2024-12-31: $574.5K2025-12-31: $654.8K$654.8K
2021-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$654.8K+14.0%2026-03-25, Balance as of period end
2024-12-31$574.5K-1.0%2026-03-25, Balance as of period end
2023-12-31$580.2K+256.5%2025-09-23, Balance as of period end
2022-12-31$162.7K-75.4%2024-03-27, Balance as of period end
2021-12-31$661.8Kn/a2023-03-27, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Nexalin Technology, Inc. (NXL)2025-12-31$654.8K+14.0%
iTonic Holdings Ltd (ITOC)2025-12-31$1.49M-75.8%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$255.7K-33.2%
Neuraxis, Inc (NRXS)2025-12-31$4.97M+34.3%
Yubo International Biotech Ltd (YBGJ)2025-12-31$8.1K+14.9%
Nuwellis, Inc. (NUWE)2025-12-31$1.08M-78.7%
Escalon Medical Corp (ESMC)2026-06-30$3.07M+461.6%
Hyperfine, Inc. (HYPR)2025-12-31$35.09M-6.8%
QT Imaging Holdings, Inc. (QTI)2025-12-31$10.41M+788.4%

Compare NXL, ITOC, ADMT, NRXS side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗